Gene · 7321
NIH grants1,455
NIH grants whose papers are about the gene, through NIH's grant-paper links.
481 to 500 of 1,455
Download this page as JSON| Grant | Title | UBE2D1 papers | Newest fiscal year |
|---|---|---|---|
| F99CA253717 | Using chemoproteomic approaches to expand upon induced-proximity modalities for cancer therapy | 1 | 2020 |
| F99CA253754 | Expanding pharmacological modalities for targeted cancer therapy | 1 | 2020 |
| K01AG052627 | Mechanisms Controlling BubR1 Regulation of Cancer and Aging | 1 | 2020 |
| K08CA208013 | Oncogenic programs driven by notch signaling in B-cell lymphoma | 1 | 2020 |
| K22CA204354 | The role of macroH2A-ZMYM3 in genome stability and tumorigenesis | 1 | 2020 |
| P20GM103548 | Center for Cancer Biology | 1 | 2020 |
| P30AG010133 | Indiana Alzheimer Disease Center | 1 | 2020 |
| P30AG019610 | Arizona Alzheimer's Disease Core Center | 1 | 2020 |
| P30AG028383 | University of Kentucky Alzheimer's Disease Core Center | 1 | 2020 |
| R00DK103126 | The role of kinase signaling in intestinal epithelial homeostasis | 1 | 2020 |
| R00ES025835 | Defining the roles of ubiquitination during the environmental stress response | 1 | 2020 |
| R01AI123406 | Non-canonical mechanisms of translation of viral mRNAs | 1 | 2020 |
| R01CA156744 | The role of FBXW2 as a novel lung tumor suppressor that cross-talks with oncogenic beta-TrCP and SKP2 | 1 | 2020 |
| R01CA200787 | Development of small molecules for ERG ablation in prostate cancer | 1 | 2020 |
| R01CA201184 | Biologic and Therapeutic Significance of miR-155 in AML | 1 | 2020 |
| R01CA201309 | How HTLV-I Tax and HBZ control telomerase activity to induce adult T-cell leukemia | 1 | 2020 |
| R01CA202021 | Control of Protein Synthesis by the UPS Under Stress | 1 | 2020 |
| R01CA202963 | Targeting interplay between KLF4 and PRMT5 in carcinogenesis | 1 | 2020 |
| R01CA207272 | Development of small molecules targeting Ring1B-Bmi1 E3 ligase in leukemia | 1 | 2020 |
| R01DC015135 | Calcium-dependent functions in Hair Cells and Spiral Ganglion Neurons | 1 | 2020 |
Source NIH's project filesgene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/7321/grants?page=25